1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways [Erratum]

      Drug Design, Development and Therapy

      Dove Medical Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ren H, Li Y, Chen Y, Wang L. Drug Des Devel Ther. 2019; 13:285–290. On page 289, Figure 4 and Notes should read as follows:

          Related collections

          Author and article information

          Journal
          Drug Des Devel Ther
          Drug Des Devel Ther
          Drug Design, Development and Therapy
          Drug Design, Development and Therapy
          Dove Medical Press
          1177-8881
          2019
          31 January 2019
          31 January 2019
          : 13
          : 499-500
          Article
          dddt-13-499
          10.2147/DDDT.S202671
          6363484
          © 2019 Ren et al. This work is published and licensed by Dove Medical Press Limited

          The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

          Categories
          Erratum

          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article